Pathological features of the differentiation landscape in esophageal squamous cell cancer and their correlations with prognosis

BackgroundFor esophageal squamous cell carcinoma (ESCC), universally accepted pathological criteria for classification by differentiation degree are lacking. Tumor budding, single-cell invasion, and nuclear grade, recognized as prognostic factors in other carcinomas, have rarely been investigated fo...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Frontiers in Oncology
المؤلفون الرئيسيون:	Jiaying Deng, Lei Zhang, Zezhou Wang, Bin Li, Jiaqing Xiang, Longfei Ma, Hongcheng Zhu, Yuan Li, Kuaile Zhao
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2024-12-01
الموضوعات:	differentiation pathological features esophageal squamous cell carcinoma nuclear diameter prognosis
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1442212/full

مواد مشابهة

Extensive clinical target volume in postoperative chemoradiotherapy for esophageal squamous cell carcinoma: a phase II clinical trial (ESO-Shanghai 9)
حسب: Dashan Ai, وآخرون
منشور في: (2023-02-01)

Identification of the Germline Mutation Profile in Esophageal Squamous Cell Carcinoma by Whole Exome Sequencing
حسب: Jiaying Deng, وآخرون
منشور في: (2019-02-01)

Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
حسب: Yun Chen, وآخرون
منشور في: (2022-04-01)

Lymphocyte recovery from radiation-induced lymphopenia in locally advanced esophageal squamous cell carcinoma: correlations with prognosis and lymphocyte-related organs
حسب: Ihsuan Tseng, وآخرون
منشور في: (2023-10-01)

Epidemiological landscape of esophageal cancer in Asia: Results from GLOBOCAN 2020
حسب: Hongcheng Zhu, وآخرون
منشور في: (2023-04-01)

The genomic landscape of esophageal squamous cell carcinoma cell lines
حسب: Chao Zhang, وآخرون
منشور في: (2025-05-01)

Analysis of clinical features, prognosis and comprehensive therapeutic strategies in 261 patients with limited-stage esophageal small cell carcinoma
حسب: LIU Di, NI Jianjiao, ZHAO Kuaile, XIANG Jiaqing, ZHANG Zhen, ZHANG Junhua
منشور في: (2025-05-01)

Induction sintilimab and chemotherapy followed by concurrent chemoradiotherapy for locally advanced esophageal cancer: a proof-of-concept, single-arm, multicenter, phase 2 trialResearch in context
حسب: Dashan Ai, وآخرون
منشور في: (2024-03-01)

Neoadjuvant sintilimab and chemotherapy in patients with resectable esophageal squamous cell carcinoma: A prospective, single-arm, phase 2 trial
حسب: Zhi Zhang, وآخرون
منشور في: (2022-10-01)

Machine learning to predict occult metastatic lymph nodes along the recurrent laryngeal nerves in thoracic esophageal squamous cell carcinoma
حسب: Yiliang Zhang, وآخرون
منشور في: (2023-03-01)

Lactate-related gene signatures predict prognosis and immune profiles in esophageal squamous cell carcinoma
حسب: Xianbing Wang, وآخرون
منشور في: (2025-07-01)

Esophageal Squamous Cell Carcinoma Presenting as Two Simultaneous Adjacent Masses Confirmed by Pathologic Findings: Report of a Rare Case
حسب: Hamidreza Khorshidi, وآخرون
منشور في: (2018-07-01)

Pathologic complete response after neoadjuvant therapy for resectable esophageal squamous cell carcinoma: Endoscopic characteristics and implications
حسب: Peng Yuan, وآخرون
منشور في: (2025-01-01)

A combined nomogram based on radiomics and hematology to predict the pathological complete response of neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma
حسب: Yu Yang, وآخرون
منشور في: (2024-04-01)

Spectral CT - a new supplementary method for preoperative assessment of pathological grades of esophageal squamous cell carcinoma
حسب: Yi Wang, وآخرون
منشور في: (2023-08-01)

Neoadjuvant chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma: Data from literature review and a real‐world analysis
حسب: Yao Zhang, وآخرون
منشور في: (2024-05-01)

Comparative transcriptome characterization of esophageal squamous cell carcinoma and adenocarcinoma
حسب: Xianfeng Li, وآخرون
منشور في: (2023-01-01)

Dimethyl fumarate alleviates allergic asthma by strengthening the Nrf2 signaling pathway in regulatory T cells
حسب: Yanhong Cen, وآخرون
منشور في: (2024-04-01)

Adjuvant strategies for patients with T1b invasion after endoscopic submucosal dissection for esophageal squamous cell carcinoma
حسب: ZHU Kaiyuan, وآخرون
منشور في: (2024-01-01)

Minimal residual disease profiling predicts pathological complete response in esophageal squamous cell carcinoma
حسب: Pinli Yue, وآخرون
منشور في: (2024-05-01)

Exploring perceived restoration, landscape perception, and place attachment in historical districts: insights from diverse visitors
حسب: Jiaying Li, وآخرون
منشور في: (2023-08-01)

TLR4 promoter rs1927914 variant contributes to the susceptibility of esophageal squamous cell carcinoma in the Chinese population
حسب: Jiaying Li, وآخرون
منشور في: (2021-02-01)

Modification of Pathological Nodal Classification for pT1b Esophageal Squamous Cell Carcinoma With Lymphovascular Invasion: Over 10‐Year Experience
حسب: Jin‐bo Li, وآخرون
منشور في: (2025-10-01)

Recurrence index predicts the prognosis of patients with pathological T1 esophageal squamous cell carcinoma
حسب: Ling C, وآخرون
منشور في: (2022-03-01)

Survival and Perioperative Outcomes After Addition of Immunotherapy to Neoadjuvant Chemoradiotherapy for the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma
حسب: Canjun Li, وآخرون
منشور في: (2025-04-01)

Nomogram for predicting pathologic complete response to neoadjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma
حسب: Guihong Liu, وآخرون
منشور في: (2024-03-01)

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort
حسب: Wei‐Xiang Qi, وآخرون
منشور في: (2023-06-01)

Efficacy and safety of anti-PD-1 antibody plus chemoradiotherapy in locally advanced esophageal squamous cancer
حسب: Ji Ma, وآخرون
منشور في: (2023-02-01)

Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016
حسب: Xin Wang, وآخرون
منشور في: (2023-06-01)

CT-based delta-radiomics for predicting pathological response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma: a multicenter study
حسب: Yuting Zheng, وآخرون
منشور في: (2024-12-01)

Comprehensive genomic and transcriptomic analyses reveal prognostic stratification for esophageal squamous cell carcinoma
حسب: Jian Gao, وآخرون
منشور في: (2025-07-01)

Patterns and prognostic predictive value of perineural invasion in esophageal squamous cell carcinoma
حسب: Yu Ma, وآخرون
منشور في: (2022-12-01)

Immune checkpoint inhibitors combined with or without radio(chemo)therapy for locally advanced or recurrent/metastatic esophageal squamous cell carcinoma
حسب: Xiao-Han Zhao, وآخرون
منشور في: (2023-09-01)

Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma
حسب: Gang Ji, وآخرون
منشور في: (2024-04-01)

Analysis of pathological remission degree and influencing factors of radical surgery after neoadjuvant immunotherapy combined with chemotherapy in patients with locally advanced esophageal squamous cell carcinoma
حسب: LIAO Ziyi, PENG Yang, ZENG Beilei, MA Yingying, ZENG Li, GAN Kelun, MA Daiyuan
منشور في: (2024-07-01)

Potential biomarkers develop for predicting the prognosis of patients with esophageal squamous cell carcinoma after optimized chemoradiotherapy using serum metabolomics
حسب: Jie Yang, وآخرون
منشور في: (2025-03-01)

Comparison of pathologic response and survival outcomes between neoadjuvant chemoradiotherapy (nCRT) and neoadjuvant immunochemotherapy (nICT) in patients with locally advanced esophageal squamous cell carcinoma: a propensity score-matched analysis
حسب: Yi Wang, وآخرون
منشور في: (2024-10-01)

Pathological responses to neoadjuvant immunochemotherapy: implications for survival and recurrence in patients with locally advanced esophageal squamous cell carcinoma
حسب: Yixin Li, وآخرون
منشور في: (2025-10-01)

A phase II clinical trial of toripalimab combined with neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma (NEOCRTEC1901)Research in context
حسب: Rui Chen, وآخرون
منشور في: (2023-08-01)

Genomic characterization of a newly established esophageal squamous cell carcinoma cell line from China and published esophageal squamous cell carcinoma cell lines
حسب: Xiang Li, وآخرون
منشور في: (2020-05-01)